Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243277761> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4243277761 abstract "Abstract Background: Neonatal hypoxic-ischemic encephalopathy (HIE) affects as many as 100,000 infants each year in China. Therapeutic hypothermia reduces HIE related mortality and long-term neurodevelopmental disabilities. National guidelines for HIE management were published a decade ago. This study aimed to investigate the current status of HIE diagnosis and treatment in China. Method: This prospective cross-sectional national survey used a questionnaire evaluating practices related to HIE management. Descriptive statistics and Chi-square or Fisher's exact test were used, and a p-value of <0.05 was considered significant. Results: The 273 hospitals that completed the survey were located in 31 of the 34 provincial districts in China. Eighty-eight percent of the hospitals were Level III hospitals, and 74% treated ten or more HIE cases annually. Awareness rates of the national guidelines for HIE diagnosis, HIE treatment, and therapeutic hypothermia protocol were 85%, 63%, and 78%, respectively. Neurological manifestations and blood gas were used as HIE diagnostic criteria by 96% (263/273) and 68% (186/273) of the hospitals, respectively. Therapeutic hypothermia was used in 54% (147/273) of hospitals. The percentage of general hospitals that implemented therapeutic hypothermia (43%, 71/165) was significantly lower than that in maternity and infant hospitals (67%, 49/73) (χ2=11.752, p=0.001) and children’s hospitals (77%, 27/35) (χ2=13.446, p<0.001). Reasons for not providing therapeutic hypothermia included reduction of HIE cases in recent years (39%), high cost of cooling devices and treatment (31%), lack of training (26%), and safety concerns (4%). Among the hospitals that provided therapeutic hypothermia, 27% (39/147) were in full compliance with the recommended protocol. Eighty-one percent (222/273) of the hospitals treated HIE infants with putative neuroprotective agents alone or in combination with cooling. Ninety-one percent of the hospitals had long-term neurodevelopmental follow-up programs for infants with HIE. Conclusions: There is significant heterogeneity in HIE diagnosis and treatment in China. Therapeutic hypothermia has not become a standard of care for neonatal HIE nationwide. Unproven agents are widely used for HIE treatment. Nationwide standardization of HIE management and dissemination of therapeutic hypothermia represent the opportunities to reduce mortality and improve long-term neurodevelopmental outcomes of children affected by HIE." @default.
- W4243277761 created "2022-05-12" @default.
- W4243277761 creator A5003807314 @default.
- W4243277761 creator A5004492315 @default.
- W4243277761 creator A5011795491 @default.
- W4243277761 creator A5019081064 @default.
- W4243277761 creator A5027406693 @default.
- W4243277761 creator A5029360035 @default.
- W4243277761 creator A5037235737 @default.
- W4243277761 creator A5043545381 @default.
- W4243277761 creator A5049030418 @default.
- W4243277761 creator A5076668990 @default.
- W4243277761 creator A5085882063 @default.
- W4243277761 date "2021-02-19" @default.
- W4243277761 modified "2023-09-26" @default.
- W4243277761 title "Neonatal Hypoxic-Ischemic Encephalopathy Diagnosis and Treatment: A National Survey in China" @default.
- W4243277761 doi "https://doi.org/10.21203/rs.3.rs-244799/v1" @default.
- W4243277761 hasPublicationYear "2021" @default.
- W4243277761 type Work @default.
- W4243277761 citedByCount "0" @default.
- W4243277761 crossrefType "posted-content" @default.
- W4243277761 hasAuthorship W4243277761A5003807314 @default.
- W4243277761 hasAuthorship W4243277761A5004492315 @default.
- W4243277761 hasAuthorship W4243277761A5011795491 @default.
- W4243277761 hasAuthorship W4243277761A5019081064 @default.
- W4243277761 hasAuthorship W4243277761A5027406693 @default.
- W4243277761 hasAuthorship W4243277761A5029360035 @default.
- W4243277761 hasAuthorship W4243277761A5037235737 @default.
- W4243277761 hasAuthorship W4243277761A5043545381 @default.
- W4243277761 hasAuthorship W4243277761A5049030418 @default.
- W4243277761 hasAuthorship W4243277761A5076668990 @default.
- W4243277761 hasAuthorship W4243277761A5085882063 @default.
- W4243277761 hasBestOaLocation W42432777611 @default.
- W4243277761 hasConcept C126322002 @default.
- W4243277761 hasConcept C187212893 @default.
- W4243277761 hasConcept C194828623 @default.
- W4243277761 hasConcept C2777390192 @default.
- W4243277761 hasConcept C2778621155 @default.
- W4243277761 hasConcept C2909832856 @default.
- W4243277761 hasConcept C42219234 @default.
- W4243277761 hasConcept C71924100 @default.
- W4243277761 hasConceptScore W4243277761C126322002 @default.
- W4243277761 hasConceptScore W4243277761C187212893 @default.
- W4243277761 hasConceptScore W4243277761C194828623 @default.
- W4243277761 hasConceptScore W4243277761C2777390192 @default.
- W4243277761 hasConceptScore W4243277761C2778621155 @default.
- W4243277761 hasConceptScore W4243277761C2909832856 @default.
- W4243277761 hasConceptScore W4243277761C42219234 @default.
- W4243277761 hasConceptScore W4243277761C71924100 @default.
- W4243277761 hasLocation W42432777611 @default.
- W4243277761 hasOpenAccess W4243277761 @default.
- W4243277761 hasPrimaryLocation W42432777611 @default.
- W4243277761 hasRelatedWork W10187606 @default.
- W4243277761 hasRelatedWork W11269607 @default.
- W4243277761 hasRelatedWork W13148500 @default.
- W4243277761 hasRelatedWork W14513556 @default.
- W4243277761 hasRelatedWork W1541014 @default.
- W4243277761 hasRelatedWork W16311502 @default.
- W4243277761 hasRelatedWork W2008714 @default.
- W4243277761 hasRelatedWork W6711125 @default.
- W4243277761 hasRelatedWork W11644164 @default.
- W4243277761 hasRelatedWork W7589222 @default.
- W4243277761 isParatext "false" @default.
- W4243277761 isRetracted "false" @default.
- W4243277761 workType "article" @default.